SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes – Brookline Capital Markets

AFFILIATES:

HEADQUARTERS

600 Lexington Avenue, 30th Floor
New York, New York 10022
(646) 603-6716

LINKS

Securities Offered Through Arcadia Securities, LLC – Member FINRA/SIPC

FINRA BROKER CHECK

Arcadia Securities LLC Form CRS

Arcadia Securities LLC Reg BI

Order routing information can be accessed through the following link by inputting Arcadia Securities: https://www.orderroutingdisclosure.com/.

© 2022 Brookline Capital Markets. All rights reserved